Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Adiponectin a Marker of Heart Risk in Diabetics

By HospiMedica staff writers
Posted on 01 Feb 2005
Researchers have found that circulating levels of adiponectin, a protein hormone produced and secreted exclusively by adipocytes (fat cells) that regulates the metabolism of lipids and glucose, are inversely related to the incidence of cardiovascular disease in patients with type I diabetes (juvenile diabetes).

Adiponectin is a 247 amino acid protein consisting of an N-terminal collagen-like domain and a C-terminal globular domain. More...
The globular domain shares significant homology to the globular domains of type VIII and X collagens, subunits of the complement factor C1q. The 2.1 angstromÅresolution crystal structure of the globular domain of adiponectin reveals significant homology to the TNF (tumor necrosis factor) family. Serum levels of adiponectin are significantly decreased in both obesity and type-2-diabetes, indicating a possible metabolic role or relationship to insulin resistance.

In the current study, investigators at the University of Pittsburgh (PA, USA; www.pitt.edu) determined adiponectin levels in patients selected from the Pittsburgh Epidemiology of Diabetes Complications Study, a 10-year prospective follow-up study of childhood onset type I diabetes mellitus. Twenty-eight diabetes patients with a history of coronary artery disease were tested along with 34 controls that were matched for gender, age, and duration of diabetes.

They reported in the January 2005 issue of Diabetologia that adiponectin levels were significantly higher in women (average of 20.8 micrograms per milliliter) than in men (average of 16.5 micrograms per milliliter). They also found that the higher the adiponectin level, the lower the likelihood that the patient suffered from cardiovascular disease.

"There was a remarkable 63% reduction in risk of coronary artery disease for each 6.3 microgram per milliliter increase in serum adiponectin levels,” said senior author Dr. Trevor Orchard, professor of epidemiology, medicine, and pediatrics at the University of Pittsburgh. "These results are striking despite the relatively small number of patients in the study. Our results--the first to show such a strong predictive power for heart disease prospectively in any population--raise the possibility that adiponectin concentration may prove not only a useful marker of cardiovascular risk, but also a potential therapeutic agent for prevention, particularly among high-risk individuals.”



Related Links:
University of Pittsburgh

Gold Member
Neonatal Heel Incision Device
Tenderfoot
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Vessel Sealing Instrument
ERGOseal
Medical-Grade Display
HL2316SHTB
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.